Ausgabe 8/2009
Inhalt (9 Artikel)
Current Opinion
Do Nanomedicines Require Novel Safety Assessments to Ensure their Safety for Long-Term Human Use?
Peter Hoet, Barbara Legiest, Jorina Geys, Benoit Nemery
Review Article
Serenoa repens (Saw Palmetto)
Taofikat B. Agbabiaka, Max H. Pittler, Barbara Wider, Edzard Ernst
Short Communication
Amyotrophic Lateral Sclerosis-Like Conditions in Possible Association with Cholesterol-Lowering Drugs
Beatrice A. Golomb, Edwin K. Kwon, Sabrina Koperski, Marcella A. Evans
Original Research Article
Application of the Bow-Tie Model in Medication Safety Risk Analysis
Peter C. Wierenga, Loraine Lie-A-Huen, Sophia E. de Rooij, Niek S. Klazinga, Henk-Jan Guchelaar, Susanne M. Smorenburg
Original Research Article
Thiazolidinediones and Cardiovascular Events in Patients with Type 2 Diabetes Mellitus
Fei-Yuan Hsiao, Weng-Foung Huang, Yu-Wen Wen, Pei-Fen Chen, Ken N. Kuo, Yi-Wen Tsai
Original Research Article
Remedies Containing Asteraceae Extracts
Elke Jeschke, Thomas Ostermann, Claudia Lüke, Manuela Tabali, Matthias Kröz, Angelina Bockelbrink, Claudia M. Witt, Stefan N. Willich, Harald Matthes
Correspondence
Comment on “Drug-Induced Thrombocytopenia: An Updated Systematic Review”
Bart L. De Keulenaer, Chan Y. Cheah